Sugi Predict

Sugi Predict / Targets / HNRNPL

HNRNPL

Heterogeneous nuclear ribonucleoprotein L · P14866 · HNRNPL on Sugi Atlas →

0 patent compounds predicted against HNRNPL, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to HNRNPL by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Application of mRNA Immunotherapy Technology in Epstein-Barr Virus-related Refractory Malignant Tumors PHASE1ACTIVE_NOT_RECRUITING
Expression Pattern of HNRNPH1 and HNRNPK Genes in MPNs nanUNKNOWN
Longitudinal Study of Neurogenetic Disorders nanRECRUITING
Diagnosis of Inflammatory Bowel Disease nanNOT_YET_RECRUITING
Association of SNPs in Long Intergenic Noncoding RNA 00511 (LINC00511) With Breast Cancer Among the Egyptian Population nanCOMPLETED
LINC00511/miR-185-3p Axis and miR-301a-3p Markers for Breast Cancer Diagnosis nanCOMPLETED
Biocollection in MyeloDysplastic Syndrome (P-MDS) nanRECRUITING
MiRNA223 and HMGB1 as Apredictos for Drug Resistant Epilepsy nanUNKNOWN
Immunophenotyping and Xist Gene in AML nanUNKNOWN
Mechanisms of Cell Death in Spinal Muscular Atrophy nanCOMPLETED
Role of SF3B1 Mutation in Assessment of Acute and Chronic Lymphatic Leukemia nanNOT_YET_RECRUITING
Micro Ribosomal Nucleic Acid 155 in Non Hodgkin Lymphoma nanCOMPLETED
Aberrant Splicings Due to Microsatellite Instability in Colorectal Cancer : Physiopathological and Clinical Impact nanUNKNOWN
Prevalence of a Non-Expressing 11B Mutation in Aka Peoples of the Central African Republic nanCOMPLETED
Liquid Biopsy for Early Detection of Colorectal Cancer Using Circular RNA nanRECRUITING
Selinexor (Nexpovio®) (SVd) in Patients With Relapsed or Refractory Multiple Myeloma nanACTIVE_NOT_RECRUITING
Na+ Channel mRNA Regulation in Heart Failure nanCOMPLETED
Assessment Of Long Noncoding RNA CCAT1 In Colorectal Cancer Patients nanUNKNOWN
SMN Circular RNAs as Potential Biomarkers for the Therapeutic Response to Nusinersen in Spinal Muscular Atrophy Patients nanUNKNOWN
Clinical Manifestations and Biomarkers in Amyotrophic Lateral Sclerosis Type 4 and Other Inherited Neurological Disorders of RNA Processing nanRECRUITING
Risk of HCC in Cirrhotic Patients Post DAAs Ttt nanUNKNOWN
The Value of circRNAs (hsa_circ_0004001) in Early Diagnosis of HCC nanUNKNOWN
The Effect of Exercise Training on lncRNA Expression in Rheumatoid Arthritis nanRECRUITING
A Study to Assess Variation in Potential Biomarkers in Friedreich Ataxia nanCOMPLETED
Identification of New FTLD Genes nanUNKNOWN
EKLF Gene Expression in β-thalassemia nanNOT_YET_RECRUITING
Pumilio1 (PUM1) Expression, Sickle Cell Anemia, β-thalassemia Intermedia nanNOT_YET_RECRUITING
Smoker Extracellular Vesicles Influence on Human Bronchial Epithelial Cells nanCOMPLETED
Impact of Weight Loss on the Human Sperm Epitranscriptome nanACTIVE_NOT_RECRUITING
Molecular Disease Profile of Hematological Malignancies nanUNKNOWN

Related proteins — ESM-2 sequence neighbours (a HNRNPL binder may also engage these)

ProteinNameSimilarity
Q8R081 — 1.000 Q8R081 →
F1LQ48 — 1.000 F1LQ48 →
HNRNPLL Heterogeneous nuclear ribonucleoprotein L-like 0.987 landscape →
Q921F4 — 0.973 Q921F4 →
Q9FGL9 — 0.966 Q9FGL9 →
Q9MAC5 — 0.954 Q9MAC5 →
P70333 — 0.949 P70333 →
O88506 — 0.945 O88506 →
SNRPA U1 small nuclear ribonucleoprotein A 0.943 landscape →
Q3SZF3 — 0.943 Q3SZF3 →
Q62696 — 0.942 Q62696 →
PRKD1 Serine/threonine-protein kinase D1 0.942 landscape →
P55795 — 0.942 P55795 →
Q5RD26 — 0.942 Q5RD26 →
Q2KIR1 — 0.942 Q2KIR1 →
Q6NXG1 — 0.942 Q6NXG1 →
Q863I2 — 0.941 Q863I2 →
STK39 STE20/SPS1-related proline-alanine-rich protein kinase 0.941 landscape →
Q91YE7 — 0.941 Q91YE7 →
Q921F2 — 0.941 Q921F2 →
Q1RMU5 — 0.941 Q1RMU5 →
Q6AY09 — 0.941 Q6AY09 →
Q6P9R2 — 0.940 Q6P9R2 →
B2GV05 — 0.940 B2GV05 →
Q1ECX4 — 0.940 Q1ECX4 →
P52756 — 0.940 P52756 →
O35737 — 0.939 O35737 →
Q06AA4 — 0.939 Q06AA4 →
A0A8I5ZNK2 — 0.939 A0A8I5ZNK2 →
B2RYD2 — 0.939 B2RYD2 →